{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:03:07Z","timestamp":1774382587924,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.coph.2012.01.019","type":"journal-article","created":{"date-parts":[[2012,2,25]],"date-time":"2012-02-25T02:43:25Z","timestamp":1330137805000},"page":"300-308","source":"Crossref","is-referenced-by-count":23,"title":["Bacterial lysates as a potentially effective approach in preventing acute exacerbation of COPD"],"prefix":"10.1016","volume":"12","author":[{"given":"Mario","family":"Cazzola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Rogliani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Gabriella","family":"Matera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2012.01.019_bib0005","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.coph.2012.01.019_bib0010","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.rmed.2006.10.012","article-title":"Exacerbations and lung function decline in COPD: new insights in current and ex-smokers","volume":"101","author":"Makris","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0015","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1183\/09031936.04.00014304","article-title":"ATS\/ERS Task Force Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS\/ERS position paper","volume":"23","author":"Celli","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2012.01.019_bib0020_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1513\/pats.201102-016RM","article-title":"Pharmacotherapeutic approaches to preventing acute exacerbations of chronic obstructive pulmonary disease","volume":"8","author":"Han","year":"2011","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.coph.2012.01.019_bib0025","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/pgmj.2008.072439","article-title":"Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease","volume":"85","author":"Black","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.coph.2012.01.019_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-146-8-200704170-00152","article-title":"Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial","volume":"146","author":"Aaron","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1465-9921-12-18","article-title":"Reduction of exacerbations by the PDE4 inhibitor roflumilast \u2013 the importance of defining different subsets of patients with COPD","volume":"12","author":"Rennard","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.coph.2012.01.019_bib0040","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ccm.2007.05.003","article-title":"The biology of a chronic obstructive pulmonary disease exacerbation","volume":"28","author":"Hurst","year":"2007","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0045_1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(11)61295-6","article-title":"Controversies in treatment of chronic obstructive pulmonary disease","volume":"378","author":"Rabe","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2012.01.019_bib0050_1","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2011.00007","article-title":"Acute exacerbations in COPD and their control with oral immunisation with nontypeable Haemophilus influenzae","volume":"2","author":"Clancy","year":"2011","journal-title":"Front Immun"},{"key":"10.1016\/j.coph.2012.01.019_bib0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1753465811398372","article-title":"The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease","volume":"5","author":"Berim","year":"2011","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.coph.2012.01.019_bib0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1378\/chest.07-0996","article-title":"Pneumococcal vaccination for patients with COPD: current practice and future directions","volume":"133","author":"Schenkein","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.coph.2012.01.019_bib0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/thx.2005.043323","article-title":"Clinical efficacy of anti-pneumococcal vaccination in patients with COPD","volume":"61","author":"Alfageme","year":"2006","journal-title":"Thorax"},{"issue":"Suppl. 6","key":"10.1016\/j.coph.2012.01.019_bib0075","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections \u2013 full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.coph.2012.01.019_bib0080","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.rmed.2007.11.002","article-title":"Bacterial extracts for the prevention of acute exacerbations in chronic obstructive pulmonary disease: a point of view","volume":"102","author":"Cazzola","year":"2008","journal-title":"Respir Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0085","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2008-0260OC","article-title":"Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi","volume":"42","author":"Evans","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2012.01.019_bib0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1476-5381.2011.01237.x","article-title":"Inhaled innate immune ligands to prevent pneumonia","volume":"163","author":"Evans","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2012.01.019_bib0095","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CDLI.1.2.150-154.1994","article-title":"Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens","volume":"1","author":"Ruedl","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.coph.2012.01.019_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000135685","article-title":"Pattern recognition receptors and their role in innate immunity: focus on microbial protein ligands","volume":"15","author":"Areschoug","year":"2008","journal-title":"Contrib Microbiol"},{"key":"10.1016\/j.coph.2012.01.019_bib0105","first-page":"S17","article-title":"May we strengthen the human natural defenses with bacterial lysates?","volume":"3","author":"Villa","year":"2010","journal-title":"WAO J"},{"key":"10.1016\/j.coph.2012.01.019_bib0110_1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1177\/0148607107031003246","article-title":"Is there evidence that the gut contributes to mucosal immunity in humans?","volume":"31","author":"Kang","year":"2007","journal-title":"J Parenter Enteral Nutr"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2012.01.019_bib0115_1","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.1000092107","article-title":"Epithelial crosstalk at the microbiota\u2013mucosal interface","volume":"108","author":"Wells","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2012.01.019_bib0120","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0264-410X(98)00441-1","article-title":"Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview","volume":"17","author":"Kyd","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.coph.2012.01.019_bib0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1089\/jir.1998.18.817","article-title":"Bacterial extract OM85-BV induces interleukin-12-dependent IFN-gamma production by human CD4+ T cells","volume":"18","author":"Byl","year":"1998","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.coph.2012.01.019_bib0130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/039463200501800207","article-title":"In vitro effects of an immunostimulating bacterial lysate on human lymphocyte function","volume":"18","author":"Lanzilli","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"Suppl. 3","key":"10.1016\/j.coph.2012.01.019_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000196126","article-title":"Influence of OM-85 BV on different humoral and cellular immune defense mechanisms of the respiratory tract","volume":"59","author":"Emmerich","year":"1992","journal-title":"Respiration"},{"key":"10.1016\/j.coph.2012.01.019_bib0140","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/thorax.55.8.678","article-title":"Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines","volume":"55","author":"Roth","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.coph.2012.01.019_bib0145","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1128\/IAI.64.3.714-718.1996","article-title":"Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model","volume":"64","author":"Barton","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.coph.2012.01.019_bib0150","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/039463200601900311","article-title":"In vivo effect of an immunostimulating bacterial lysate on human B lymphocytes","volume":"19","author":"Lanzilli","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.coph.2012.01.019_bib0155","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/IAI.72.5.2679-2688.2004","article-title":"Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses","volume":"72","author":"Rial","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.coph.2012.01.019_bib0160","first-page":"418","article-title":"IgG deficiency in adults with recurrent respiratory infections","volume":"70","author":"Popa","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.coph.2012.01.019_bib0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0192-0561(89)90149-5","article-title":"Stimulation by a bacterial extract (Broncho-Vaxom) of the metabolic and functional activities of murine macrophages","volume":"11","author":"Mauel","year":"1989","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.coph.2012.01.019_bib0170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2249.2011.04320.x","article-title":"Sublingual therapeutic immunization with a polyvalent bacterial preparation in patients with recurrent respiratory infections: immunomodulatory effect on antigen-specific memory CD4+ T cells and impact on clinical outcome","volume":"164","author":"Alecsandru","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coph.2012.01.019_bib0175","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2010.04.013","article-title":"Persistence of mucosal and systemic immune responses following sublingual immunization","volume":"28","author":"Negri","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coph.2012.01.019_bib0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00290-0","article-title":"Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels","volume":"86","author":"Rossi","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coph.2012.01.019_bib0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.imlet.2011.03.006","article-title":"A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells","volume":"138","author":"Morandi","year":"2011","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coph.2012.01.019_bib0190_1","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1378\/chest.126.5.1645","article-title":"Oral purified bacterial extracts in chronic bronchitis and COPD","volume":"126","author":"Steurer-Stey","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.coph.2012.01.019_bib0195_1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1081\/COPD-200050674","article-title":"Clinical efficacy of OM-85 BV in COPD and chronic bronchitis: a systematic review","volume":"2","author":"Sprenkle","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.coph.2012.01.019_bib0200_1","article-title":"Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis","author":"Cazzola","year":"2011","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.coph.2012.01.019_bib0205","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000093933","article-title":"Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease","volume":"74","author":"Sol\u00e8r","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.coph.2012.01.019_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1753465809104677","article-title":"Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol\/fluticasone","volume":"3","author":"Cazzola","year":"2009","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.coph.2012.01.019_bib0215","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0220","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","article-title":"Outcomes for COPD pharmacological trials: from lung function to biomarkers","volume":"31","author":"Cazzola","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2012.01.019_bib0225_1","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0230","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1378\/chest.10-2948","article-title":"The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study","volume":"140","author":"Kim","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.coph.2012.01.019_bib0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.09-1382","article-title":"Oral immunotherapy with inactivated nontypeable Haemophilus influenzae reduces severity of acute exacerbations in severe COPD","volume":"137","author":"Tandon","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.coph.2012.01.019_bib0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2249.2010.04142.x","article-title":"Oral non-typable Haemophilus influenzae enhances physiological mechanism of airways protection","volume":"161","author":"Clancy","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.coph.2012.01.019_bib0245","first-page":"85","article-title":"Vaccine prophylaxis in respiratory infections: efficacy of a bacterial lysate by mechanical lysis","volume":"56","author":"Blasi","year":"2002","journal-title":"Giorn It Mal Tor"},{"key":"10.1016\/j.coph.2012.01.019_bib0250","first-page":"477","article-title":"The relationship between mucosal immunoresponse and clinical outcome in patients with recurrent upper respiratory tract infections treated with a mechanical bacterial lysate","volume":"25","author":"Braido","year":"2011","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.coph.2012.01.019_bib0255","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2807\/esm.09.01.00441-en","article-title":"The European community strategy against antimicrobial resistance","volume":"9","author":"Bronzwaer","year":"2004","journal-title":"Euro Surveill"},{"key":"10.1016\/j.coph.2012.01.019_bib0260","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1164\/ajrccm.156.6.9612096","article-title":"Effects of an immunostimulating agent on acute exacerbations and hospitalizations in patients with chronic obstructive pulmonary disease","volume":"156","author":"Collet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0265","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.rmed.2006.06.029","article-title":"Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis","volume":"100","author":"Arandjus","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.coph.2012.01.019_bib0270","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1183\/09031936.94.07030446","article-title":"Oral immunization with bacterial extracts for protection against acute bronchitis in elderly institutionalized patients with chronic bronchitis","volume":"7","author":"Orcel","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1016\/j.coph.2012.01.019_bib0275","first-page":"207","article-title":"Immunotherapy of recurrent respiratory infections: double-blind study of a new immunomodulator in 60 patients","volume":"42","author":"Germouty","year":"1986","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.coph.2012.01.019_bib0280","first-page":"81","article-title":"Prophylaxis for acute exacerbations of chronic bronchitis using an antibacterial sublingual vaccine obtained through mechanical lysis: a clinical and pharmacoeconomic study","volume":"74","author":"Cogo","year":"2003","journal-title":"Acta Biomed"},{"key":"10.1016\/j.coph.2012.01.019_bib0285","first-page":"199","article-title":"A new bacterial lysate protects by reducing infections exacerbations in moderate to very severe COPD","volume":"6","author":"Cazzola","year":"2006","journal-title":"Trends Med"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489212000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T22:42:43Z","timestamp":1640904163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489212000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1471489212000215"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2012.01.019","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}